These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30012567)

  • 1. Metformin Inhibits Prostate Cancer Progression by Targeting Tumor-Associated Inflammatory Infiltration.
    Liu Q; Tong D; Liu G; Gao J; Wang LA; Xu J; Yang X; Xie Q; Huang Y; Pang J; Wang L; He Y; Zhang D; Ma Q; Lan W; Jiang J
    Clin Cancer Res; 2018 Nov; 24(22):5622-5634. PubMed ID: 30012567
    [No Abstract]   [Full Text] [Related]  

  • 2. Metformin inhibits castration-induced EMT in prostate cancer by repressing COX2/PGE2/STAT3 axis.
    Tong D; Liu Q; Liu G; Xu J; Lan W; Jiang Y; Xiao H; Zhang D; Jiang J
    Cancer Lett; 2017 Mar; 389():23-32. PubMed ID: 28043910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.
    Narayanan BA; Narayanan NK; Pittman B; Reddy BS
    Clin Cancer Res; 2004 Nov; 10(22):7727-37. PubMed ID: 15570007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin represses androgen-dependent and androgen-independent prostate cancers by targeting androgen receptor.
    Wang Y; Liu G; Tong D; Parmar H; Hasenmayer D; Yuan W; Zhang D; Jiang J
    Prostate; 2015 Aug; 75(11):1187-96. PubMed ID: 25894097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic Lethal Metabolic Targeting of Androgen-Deprived Prostate Cancer Cells with Metformin.
    Yang B; Damodaran S; Khemees TA; Filon MJ; Schultz A; Gawdzik J; Etheridge T; Malin D; Richards KA; Cryns VL; Jarrard DF
    Mol Cancer Ther; 2020 Nov; 19(11):2278-2287. PubMed ID: 32943543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory therapies in TRAMP mice: delay in PCa progression.
    Kido LA; Montico F; Sauce R; Macedo AB; Minatel E; Costa DB; Carvalho JE; Pilli RA; Cagnon VH
    Endocr Relat Cancer; 2016 Apr; 23(4):235-50. PubMed ID: 26772819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen-independent prostate cancer progression in the TRAMP model.
    Gingrich JR; Barrios RJ; Kattan MW; Nahm HS; Finegold MJ; Greenberg NM
    Cancer Res; 1997 Nov; 57(21):4687-91. PubMed ID: 9354422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of MyD88 leads to more aggressive TRAMP prostate cancer and influences tumor infiltrating lymphocytes.
    Peek EM; Song W; Zhang H; Huang J; Chin AI
    Prostate; 2015 Apr; 75(5):463-73. PubMed ID: 25597486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin targets c-MYC oncogene to prevent prostate cancer.
    Akinyeke T; Matsumura S; Wang X; Wu Y; Schalfer ED; Saxena A; Yan W; Logan SK; Li X
    Carcinogenesis; 2013 Dec; 34(12):2823-32. PubMed ID: 24130167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bitter melon extract impairs prostate cancer cell-cycle progression and delays prostatic intraepithelial neoplasia in TRAMP model.
    Ru P; Steele R; Nerurkar PV; Phillips N; Ray RB
    Cancer Prev Res (Phila); 2011 Dec; 4(12):2122-30. PubMed ID: 21911444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR7 expression is decreased during tumour progression in transgenic adenocarcinoma of mouse prostate mice and its activation inhibits growth of prostate cancer cells.
    Han JH; Park SY; Kim JB; Cho SD; Kim B; Kim BY; Kang MJ; Kim DJ; Park JH; Park JH
    Am J Reprod Immunol; 2013 Oct; 70(4):317-26. PubMed ID: 23790156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reciprocal Network between Cancer Stem-Like Cells and Macrophages Facilitates the Progression and Androgen Deprivation Therapy Resistance of Prostate Cancer.
    Huang H; Wang C; Liu F; Li HZ; Peng G; Gao X; Dong KQ; Wang HR; Kong DP; Qu M; Dai LH; Wang KJ; Zhou Z; Yang J; Yang ZY; Cheng YQ; Tian QQ; Liu D; Xu CL; Xu DF; Cui XG; Sun YH
    Clin Cancer Res; 2018 Sep; 24(18):4612-4626. PubMed ID: 29691294
    [No Abstract]   [Full Text] [Related]  

  • 13. Nuclear Receptor Corepressor 1 Expression and Output Declines with Prostate Cancer Progression.
    Lopez SM; Agoulnik AI; Zhang M; Peterson LE; Suarez E; Gandarillas GA; Frolov A; Li R; Rajapakshe K; Coarfa C; Ittmann MM; Weigel NL; Agoulnik IU
    Clin Cancer Res; 2016 Aug; 22(15):3937-49. PubMed ID: 26968201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbidopa enhances antitumoral activity of bicalutamide on the androgen receptor-axis in castration-resistant prostate tumors.
    Thomas C; Wafa LA; Lamoureux F; Cheng H; Fazli L; Gleave ME; Rennie PS
    Prostate; 2012 Jun; 72(8):875-85. PubMed ID: 22072572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Efflux Transporter ABCG2 Maintains Prostate Stem Cells.
    Sabnis NG; Miller A; Titus MA; Huss WJ
    Mol Cancer Res; 2017 Feb; 15(2):128-140. PubMed ID: 27856956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Icaritin suppresses development of neuroendocrine differentiation of prostate cancer through inhibition of IL-6/STAT3 and Aurora kinase A pathways in TRAMP mice.
    Sun F; Zhang ZW; Tan EM; Lim ZLR; Li Y; Wang XC; Chua SE; Li J; Cheung E; Yong EL
    Carcinogenesis; 2016 Jul; 37(7):701-711. PubMed ID: 27207661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic ablation of the amplified-in-breast cancer 1 inhibits spontaneous prostate cancer progression in mice.
    Chung AC; Zhou S; Liao L; Tien JC; Greenberg NM; Xu J
    Cancer Res; 2007 Jun; 67(12):5965-75. PubMed ID: 17575167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of MUC18 correlates with the metastatic progression of mouse prostate adenocarcinoma in the TRAMP model.
    Wu GJ; Fu P; Chiang CF; Huss WJ; Greenberg NM; Wu MW
    J Urol; 2005 May; 173(5):1778-83. PubMed ID: 15821586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of C-CAM cell adhesion molecule in prostate carcinogenesis in a transgenic mouse model.
    Pu YS; Luo W; Lu HH; Greenberg NM; Lin SH; Gingrich JR
    J Urol; 1999 Sep; 162(3 Pt 1):892-6. PubMed ID: 10458403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzyl Isothiocyanate Inhibits Prostate Cancer Development in the Transgenic Adenocarcinoma Mouse Prostate (TRAMP) Model, Which Is Associated with the Induction of Cell Cycle G1 Arrest.
    Cho HJ; Lim DY; Kwon GT; Kim JH; Huang Z; Song H; Oh YS; Kang YH; Lee KW; Dong Z; Park JH
    Int J Mol Sci; 2016 Feb; 17(2):264. PubMed ID: 26907265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.